Table 2 Crude and Adjusted Odds Ratios for Four Outcomes: Nesiritide compared to No Nesiritide (n = 25,330)
Outcome | ||||
|---|---|---|---|---|
Type of odds ratio | Hospital mortality OR† (95% CI‡) | Prolonged length of stay OR (95% CI) | Elevated pharmacy cost OR (95% CI) | Readmission within 31 days for cardiac condition OR (95% CI) |
Unadjusted | 1.59 (1.31–1.93) | 2.41 (2.21–2.62) | 6.24 (5.72–6.80) | 1.11 (0.89–1.39) |
Adjusted for 9 medications* | 1.26 (1.00–1.58) | 1.89 (1.72–2.06) | 5.35 (4.88–5.86) | 1.14 (0.90–1.44) |
Adjusted for APR-DRG severity of illness score | 1.04 (0.85–1.27) | 1.99 (1.82–2.19) | 6.24 (5.67–6.87) | 1.14 (0.91–1.42) |
Adjusted for 9 medications, APR-DRG severity of illness score, race, and low economic status | 1.07 (0.85–1.35) | 1.66 (1.51–1.83) | 5.45 (4.93–6.01) | 1.15 (0.91–1.45) |
Adjusted for APR-DRG risk of mortality score | 1.03 (0.84–1.27) | N/A | N/A | N/A |
Adjusted for APR-DRG risk of mortality score, 9 medications, race, and low economic status | 1.06 (0.84–1.35) | N/A | N/A | N/A |